Citation Impact
Citing Papers
Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
2013 Standout
Emergence and control of infectious diseases in China
2008
Study of hepatitis C virus entry in genetically humanized mice
2012 StandoutNobel
Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents
2013
An Alpaca Nanobody Inhibits Hepatitis C Virus Entry And Cell-To-Cell Transmission
2013
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
2013
Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
2012
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Lead heavy metal toxicity induced changes on growth and antioxidative enzymes level in water hyacinths [Eichhornia crassipes (Mart.)]
2014
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
2020 StandoutNobel
Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice
2009
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Taming a beast: lessons from the domestication of hepatitis C virus
2019 StandoutNobel
Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C
2013
Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis
2016
Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice
2012
VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease
2015
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Review of Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C
2012
Different Effects of Six Antibiotics and Ten Traditional Chinese Medicines on Shiga Toxin Expression byEscherichia coliO157:H7
2013
Interferon-Free Regimens in the Liver-Transplant Setting
2014
A Comprehensive Computational Analysis for the Binding Modes of Hepatitis C Virus NS5A Inhibitors: The Question of Symmetry
2016 StandoutNobel
Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C
2014
Progress towards a hepatitis C virus vaccine
2013 StandoutNobel
Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.
2012
Fast Hepatitis C Virus RNA Elimination and NS5A Redistribution by NS5A Inhibitors Studied by a Multiplex Assay Approach
2015 StandoutNobel
Reactive oxygen species (ROS) and response of antioxidants as ROS-scavengers during environmental stress in plants
2014 Standout
Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials
2020 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Griffithsin Has Antiviral Activity against Hepatitis C Virus
2011
Malva species: Insights on its chemical composition towards pharmacological applications
2019
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery
2019 Standout
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
2014 StandoutNobel
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Works of Xia Luo being referenced
Lead toxicity induced growth and antioxidant responses in Luffa cylindrica seedlings.
2010
Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus
2011
Astragaloside exerts anti-photoaging effects in UVB-induced premature senescence of rat dermal fibroblasts through enhanced autophagy
2018
A Novel Escherichia coli O157:H7 Clone Causing a Major Hemolytic Uremic Syndrome Outbreak in China
2012
Spread ofStreptococcus suisSequence Type 7, China
2008
Clinical drug‐drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P‐glycoprotein
2014
THU0141 Biomarker assessment of VX-509, an investigational selective JAK3 inhibitor, in healthy volunteers
2012
Effect of Telaprevir on the Pharmacokinetics of Buprenorphine in Volunteers on Stable Buprenorphine/Naloxone Maintenance Therapy
2012
8 POTENT HCV PROTEASE INHIBITORS WITH THE POTENTIAL FOR ONCE-DAILY DOSING AND BROAD GENOTYPE COVERAGE
2009